Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guillaume Penaranda

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Hepatology (Baltimore, Md.)|June 29, 2007
External validation of FibroIndexPhilippe Halfon, Guillaume Penaranda, Christophe Renou, et al.
World Journal of Surgery|November 7, 2021
Intraoperative Mapping Angiograms of the Parathyroid Glands Using Indocyanine Green During Thyroid Surgery: Results of the Fluogreen StudyFares Benmiloud, Guillaume Penaranda, Laurent Chiche, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 11, 2016
HCC classification and HCC scoring system: a win-win combination for prognosis and treatment recommendationsXavier Adhoute, Guillaume Penaranda, Jean-Luc Raoul, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 28, 2017
Intermediate stage treatment: Is TACE enough?Xavier Adhoute, Guillaume Penaranda, Jean Luc Raoul, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 19, 2016
Staging of hepatocellular carcinoma: BCLC system, what else!Xavier Adhoute, Guillaume Penaranda, Jean Luc Raoul, et al.
Journal of Hepatology|February 14, 2015
Reply to: ''Repeated transarterial chemoembolization: An overfitting effort?''Xavier Adhoute, Guillaume Penaranda, Jean Luc Raoul, et al.
Journal of Hepatology|February 26, 2016
Hepatocellular carcinoma scoring and staging systems. Do we need new tools?Xavier Adhoute, Guillaume Penaranda, Jean-Luc Raoul, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 12, 2017
Prediction of benefit after transarterial chemoembolization (TACE): Subclassifications or scoring systems?Xavier Adhoute, Guillaume Penaranda, Jean-Luc Raoul, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 31, 2016
Nomogram of the Barcelona Clinic Liver Cancer System: external validation in European patientsXavier Adhoute, Guillaume Penaranda, Jean-Luc Raoul, et al.
World Journal of Hepatology|April 8, 2015
Recommendations for the use of chemoembolization in patients with hepatocellular carcinoma: Usefulness of scoring system?Xavier Adhoute, Guillaume Penaranda, Paul Castellani, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Hepatology (Baltimore, Md.)|June 29, 2007
External validation of FibroIndexPhilippe Halfon, Guillaume Penaranda, Christophe Renou, et al.
World Journal of Surgery|November 7, 2021
Intraoperative Mapping Angiograms of the Parathyroid Glands Using Indocyanine Green During Thyroid Surgery: Results of the Fluogreen StudyFares Benmiloud, Guillaume Penaranda, Laurent Chiche, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 11, 2016
HCC classification and HCC scoring system: a win-win combination for prognosis and treatment recommendationsXavier Adhoute, Guillaume Penaranda, Jean-Luc Raoul, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 28, 2017
Intermediate stage treatment: Is TACE enough?Xavier Adhoute, Guillaume Penaranda, Jean Luc Raoul, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 19, 2016
Staging of hepatocellular carcinoma: BCLC system, what else!Xavier Adhoute, Guillaume Penaranda, Jean Luc Raoul, et al.
Journal of Hepatology|February 14, 2015
Reply to: ''Repeated transarterial chemoembolization: An overfitting effort?''Xavier Adhoute, Guillaume Penaranda, Jean Luc Raoul, et al.
Journal of Hepatology|February 26, 2016
Hepatocellular carcinoma scoring and staging systems. Do we need new tools?Xavier Adhoute, Guillaume Penaranda, Jean-Luc Raoul, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 12, 2017
Prediction of benefit after transarterial chemoembolization (TACE): Subclassifications or scoring systems?Xavier Adhoute, Guillaume Penaranda, Jean-Luc Raoul, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 31, 2016
Nomogram of the Barcelona Clinic Liver Cancer System: external validation in European patientsXavier Adhoute, Guillaume Penaranda, Jean-Luc Raoul, et al.
World Journal of Hepatology|April 8, 2015
Recommendations for the use of chemoembolization in patients with hepatocellular carcinoma: Usefulness of scoring system?Xavier Adhoute, Guillaume Penaranda, Paul Castellani, et al.
Pageof 7